Related Experiment Video
Updated: Sep 1, 2025

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
Comprehensive Management of Inflammatory Bowel Disease: What's Next
Asaf Levartovsky1, Uri Kopylov1
1Department of Gastroenterology, Sheba Medical Center Tel Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel Aviv-Yafo 52621, Israel.
Abstract:
In the last 20 years, the treatment and management of patients with Crohn's disease (CD) and ulcerative colitis (UC) have been revolutionized by the introduction of biological therapies and small molecules [...].
Insights
The last 20 years have seen major advances in treating Crohn
Area of Science:
- Gastroenterology and immunology, focusing on inflammatory bowel diseases (IBD).
Background:
- Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory bowel diseases.
- Treatment paradigms have evolved significantly over the past two decades.
Discussion:
- Biological therapies and small molecules represent a revolution in IBD management.
- These novel agents offer targeted mechanisms of action compared to traditional therapies.
Key Insights:
- Significant improvements in patient outcomes and quality of life are achievable with advanced therapies.
- Understanding the underlying immune pathways is crucial for developing effective treatments.
Outlook:
- Continued research into personalized medicine and novel therapeutic targets is essential.
- Future directions include exploring combination therapies and strategies to induce long-term remission.
More Related Videos
08:52Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes
Published on: February 5, 2021
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Irritable Bowel Syndrome III: Medical and Nursing Management